DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Capital Goods
Published
09 Feb 25
Updated
25 Aug 26
Views
203
Not Invested
JBT MarelJBTM
JBTM logo
Fair Value
US$172.64
Share price25 Aug
US$111.3835.5% undervalued intrinsic discount
Loading
1Y-18.14%
7D-3.95%

Global Protein Demand And Automation Will Drive Future Expansion

AN
AnalystConsensusTarget
AnalystConsensusTarget

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
09 Feb 25
Updated
25 Aug 26
Views
203
Not Invested
Fair ValueUS$172.64
Share priceUS$111.38
35.5% undervalued intrinsic discount
Narrative
Updates18

Last Update 25 Aug 26

Fair value Decreased 3.42%

JBTM: Integration Self Help And Recurring Revenue Will Drive Future Upside

Analysts have fine tuned their view on JBT Marel, trimming the price target from $178.75 to $172.64 as they weigh updated assumptions on profitability and valuation against ongoing integration opportunities and execution risks highlighted in recent research.

Analyst Commentary

Recent research on JBT Marel highlights a mix of optimism around the integration story and caution around the execution needed to support the current valuation.

Bullish Takeaways

  • Bullish analysts describe JBT Marel as a self help story, pointing to potential value creation through combining the JBT and Marel platforms.
  • They see room for improved profitability as integration efforts progress, which they view as underappreciated in current pricing.
  • Skepticism around the size and complexity of the deal is seen by bullish analysts as creating room for upside if execution stays on track.
  • Price targets such as US$150 and US$188 indicate that some analysts still view the stock as having headroom relative to their assessment of long term earnings power.

Bearish Takeaways

  • Bearish analysts are focused on execution risk tied to the large scale integration, which they see as a key swing factor for margins and cash flow.
  • Updated models following Q2 results point to a reliance on stronger performance in the second half of the year, which some view as a source of uncertainty for investors.
  • The reduction of price targets, including the cut from US$202 to US$188, reflects a more cautious stance on how quickly integration benefits may show up in reported numbers.
  • There is concern that if JBT Marel falls short on integration or second half delivery, the current valuation could prove demanding relative to realized earnings.

What’s in the News for JBT Marel

  • Levi & Korsinsky has started an investigation into JBT Marel after the company excluded a non cash impairment charge from its reported Q2 2026 adjusted earnings. The firm is reviewing whether any statements about profitability and adjusted results may have been materially false or misleading. Source: Levi & Korsinsky investigation notice.
  • Following the release of the adjusted Q2 2026 profit figures that omitted the impairment charge, JBT Marel’s shareholder value fell about 7.9%. Investors who saw losses tied to this move are being asked to submit their information to the investigating law firm. Source: Levi & Korsinsky investigation notice.
  • JBT Marel reported an impairment of intangible assets of US$33 million for Q2 2026 and guided to full year 2026 impairment of around US$33 million. Source: company impairment disclosure.
  • The company updated full year 2026 guidance and now expects revenue of US$3.99b to US$4.07b. It guided to GAAP diluted EPS of US$4.20 to US$4.70 and net income of US$220 million to US$245 million. Source: company guidance update.
  • JBT Marel was dropped from several Russell indices in 2026, including the Russell Small Cap Comp Growth Benchmark, the Russell 2500 Growth Benchmark, the Russell 3000 Growth Benchmark, the Russell 2000 Growth Defensive Index, the Russell 3000E Growth Benchmark, the Russell 2000 Dynamic Index and the Russell 2000 Growth Benchmark. Source: index constituent change notices.

Valuation Changes for JBT Marel

  • Fair Value has been reduced from $178.75 to $172.64, which is a small trim to the prior estimate.
  • Discount Rate remains at 9.04%, indicating only a minimal adjustment to the risk assumption applied to JBT Marel.
  • Revenue Growth assumption has moved from 4.93% to 4.96%, which is a small upward adjustment to the long term sales outlook expressed in the model.
  • Profit Margin assumption has increased from 11.94% to 12.81%, signalling a higher modeled level of long run profitability for JBT Marel.
  • Future P/E has been reduced from 22.52x to 19.25x, which lowers the valuation multiple used to value JBT Marel’s projected earnings.
Read more
5 viewsusers have viewed this narrative update

Key Takeaways

  • Strong demand for automation and integrated solutions, driven by protein consumption trends and labor challenges, positions JBT Marel for sustained revenue and market share growth.
  • Realized merger synergies, aftermarket expansion, and advanced digital offerings are enhancing margins and earnings stability, supporting long-term profitability and competitive advantage.
  • Lingering tariff pressures, integration challenges, market cyclicality, reliance on favorable FX, and unresolved supply chain shifts threaten margin stability and consistent financial performance.

Catalysts

About JBT Marel
    Provides technology solutions to food and beverage industry in North America, Europe, the Middle East, Africa, the Asia Pacific, and Central and South America.
What are the underlying business or industry changes driving this perspective?
  • The ongoing global increase in protein consumption and demand for food safety/traceability is driving sustained investment in automation and integrated processing solutions, supporting a robust order backlog (notably in poultry and meat), which is likely to provide multi-year revenue growth.
  • Labor shortages and rising labor costs across food processing are accelerating capital expenditure on automation and yield-enhancing equipment, an area where JBT Marel is seeing strong demand and is poised to capture greater market share, underpinning future topline growth.
  • The JBT-Marel merger is already realizing synergy benefits, enabling margin expansion through cost savings, portfolio breadth, increased cross-selling, and a deeper customer relationship via integrated system sales, which management expects to continue driving net margin improvement into 2027.
  • Strategic expansion in aftermarket, service, and refurbishment revenue-with high margins and recurring characteristics-both improves margin mix and enhances earnings visibility, helping to stabilize and grow free cash flow.
  • Sustained R&D investment and the integration of advanced digital/software capabilities (e.g., end-to-end traceability, automated line control, data analytics) is positioning JBT Marel to command premium pricing and defend competitive advantage, supporting long-term earnings expansion.
JBT Marel Earnings and Revenue Growth

JBT Marel Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming JBT Marel's revenue will grow by 5.0% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 4.9% today to 12.8% in 3 years time.
  • Analysts expect earnings to reach $581.5 million (and earnings per share of $10.89) by about August 2029, up from $193.3 million today.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 19.6x on those 2029 earnings, down from 31.5x today. This future PE is lower than the current PE for the US Machinery industry at 26.9x.
  • Analysts expect the number of shares outstanding to decline by 0.57% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 9.04%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Ongoing and potentially escalating global tariffs, especially the 15% rate impacting Europe and other recent tariff changes, are creating margin headwinds that may persist into 2026 despite mitigation efforts, leading to unpredictable costs and possibly hampering net margins and earnings.
  • The company is in the early stages of integrating JBT and Marel; unresolved integration risks remain, such as aligning operational structures, R&D definitions, and achieving full synergy capture, which, if delayed or inefficient, could drive up SG&A expenses and impair margin expansion.
  • Exposure to cyclical capital expenditure patterns in core protein and food processing end markets, particularly given weakness in segments like beef and volatility in regions such as Asia Pacific, introduces the risk of revenue volatility and potential order delays during macroeconomic downturns or sector-specific slowdowns.
  • The company's financial outperformance in the quarter was significantly bolstered by favorable FX translation and one-time mix benefits (recurring revenue/aftermarket strength); an unfavorable shift in currency trends or a normalization of aftermarket volume could negatively impact reported revenue and margins.
  • Supply chain reconfiguration due to tariffs-such as moving production and sourcing-has not yet advanced beyond the assessment stage, highlighting ongoing vulnerability to logistical disruptions and higher component costs, which could result in delays, increased working capital needs, and margin pressure.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $172.64 for JBT Marel based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $210.0, and the most bearish reporting a price target of just $118.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $4.5 billion, earnings will come to $581.5 million, and it would be trading on a PE ratio of 19.6x, assuming you use a discount rate of 9.0%.
  • Given the current share price of $117.93, the analyst price target of $172.64 is 31.7% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on JBT Marel?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Comments

0 comments

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

JBTM logo
JBT Marel
5.6% undervalued intrinsic discount

Alternative Proteins And Integration Setbacks Will Squeeze Margins

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 2 Jun
Read Narrative
JBTM logo
JBT Marel
47.0% undervalued intrinsic discount

Rising Global Protein Demand And Automation Will Transform Food Processing

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 2 May
Read Narrative

Fair Value vs Share Price

US$172.64
vs US$111.3835.5% undervalued intrinsic discount
PastFuture-110m5b2015201820212024202620272029Revenue US$4.5bEarnings US$581.5m
5%
Revenue growth
12.8%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on JBT Marel

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Excellent balance sheet and good value.

Market capUS$5.8b
PB1.3x
Estimated Growth4.9%
Dividend Yield0.4%
Full analysis

CEO & management

Brian Deck
CEO
4.2yrs
CEO Tenure

Provides technology solutions to food and beverage industry in the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide